Drugs / TV005
TV005
also known as
Admixture TV005 · TetraVax-DV · TetraVax-DV TV005 · TetraVax-DV Vaccine - Admixture TV005
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT02317900 | Dec 2014 → Nov 2016 | dengue disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT01506570 | Dec 2011 → Sep 2013 | dengue disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT01436422 | Aug 2011 → Mar 2014 | dengue disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT05229354 | Dec 2021 → Nov 2023 overdue | dengue disease | Beth Kirkpatrick | Active not recruiting | No outcome recorded |
| Phase 2 | NCT04133987 | Oct 2018 → Apr 2020 | dengue disease | National Taiwan University Hospital | Completed | No outcome recorded |
| Phase 2 | NCT02678455 | Mar 2016 → Aug 2017 | dengue disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TV005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02317900 ↗ |
| Known as | Admixture TV005 | “One subcutaneous injection at Day 0 and Day 180 of a live attenuated recombinant TetraVax-DV vaccine, Admixture TV005” NCT01436422 ↗ |
| Known as | TetraVax-DV | “The primary objective is to determine, among dengue-naïve adults in an endemic population, the protective efficacy of TetraVax-DV TV005 vaccine against dengue infection induced...” NCT05229354 ↗ |
| Known as | TetraVax-DV TV005 | “the Recombinant Live Attenuated Tetravalent Dengue Virus Vaccine Admixture TV005 (TetraVax-DV TV005) in Healthy Adults” NCT02678455 ↗ |
| Known as | TetraVax-DV Vaccine - Admixture TV005 | “TetraVax-DV Vaccine - Admixture TV005” NCT01506570 ↗ |
| Modality | Vaccine | “TV005 is a live attenuated recombinant tetravalent dengue virus vaccine.” NCT02317900 ↗ |
| Route | Subcutaneous | “It will be delivered by subcutaneous injection in the deltoid region of the upper arm.” NCT02317900 ↗ |